8.32
-0.07 (-0.83%)
| Penutupan Terdahulu | 8.39 |
| Buka | 8.33 |
| Jumlah Dagangan | 400,055 |
| Purata Dagangan (3B) | 751,625 |
| Modal Pasaran | 429,281,152 |
| Harga / Pendapatan (P/E Ke hadapan) | 2.08 |
| Harga / Jualan (P/S) | 0.730 |
| Harga / Buku (P/B) | 0.820 |
| Julat 52 Minggu |
| Margin Keuntungan | -13.63% |
| Margin Operasi (TTM) | 22.68% |
| EPS Cair (TTM) | -2.58 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -26.00% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 655.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 121.71% |
| Nisbah Semasa (MRQ) | 6.32 |
| Aliran Tunai Operasi (OCF TTM) | 110.10 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 91.12 M |
| Pulangan Atas Aset (ROA TTM) | -1.61% |
| Pulangan Atas Ekuiti (ROE TTM) | -21.63% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Emergent BioSolutions Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -1.50 |
|
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 2.83% |
| % Dimiliki oleh Institusi | 67.20% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Palisade Capital Management, Lp | 31 Mar 2026 | 1,201,323 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| GLESSNER COLEEN | - | 8.00 | -2,018 | -16,144 |
| HARTZEL WILLIAM | - | 8.00 | -1,741 | -13,928 |
| LINDAHL RICHARD S | - | 8.00 | -3,964 | -31,712 |
| WILLIAMS PAUL ANTHONY | - | 8.00 | -694 | -5,552 |
| Jumlah Keseluruhan Kuantiti Bersih | -8,417 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -67,336 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 8.00 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| HARTZEL WILLIAM | Pegawai | 08 Jun 2026 | Dibuang (-) | 1,741 | 8.00 | 13,928 |
| GLESSNER COLEEN | Pegawai | 08 Jun 2026 | Dibuang (-) | 2,018 | 8.00 | 16,144 |
| LINDAHL RICHARD S | Pegawai | 08 Jun 2026 | Dibuang (-) | 3,964 | 8.00 | 31,712 |
| WILLIAMS PAUL ANTHONY | Pegawai | 08 Jun 2026 | Dibuang (-) | 694 | 8.00 | 5,552 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |